SCHEMBL7689910

SCHEMBL7689910

COc1ccc(Nc2ncc3nc(-c4ccccc4)c(=O)n(C)c3n2)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 18/20 0.81
CYP1A2 P05177 18/20 0.81
CASP7 P55210 14/20 0.81
CASP1 P29466 13/20 0.81
MEN1 O00255 11/20 0.81
KMT2A Q03164 11/20 0.81
HIF1A Q16665 6/20 0.81
CYP2C19 P33261 1/20 0.81
ALDH1A1 P00352 8/20 0.79
LMNA P02545 5/20 0.79
MAPK1 P28482 2/20 0.76
CLK4 Q9HAZ1 1/20 0.76
CYP2C9 P11712 6/20 0.71
BRCA1 P38398 2/20 0.67
HBB P68871 1/20 0.67
CYP3A4 P08684 6/20 0.67
HSD17B10 Q99714 4/20 0.67
TP53 P04637 2/20 0.67
GLA P06280 1/20 0.62
GAA P10253 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7695096 0.85 EGFR (0.64) USP2CYP1A2CASP7CASP1MEN1
SCHEMBL5520426 0.83 RIPK2 (0.73) USP2CYP1A2CASP7CASP1MEN1
SCHEMBL5534904 0.81 CYP1A2 (0.74) USP2CYP1A2CASP7CASP1MEN1
SCHEMBL5520442 0.79 CYP1A2 (0.70) USP2CYP1A2CASP7CASP1MEN1
SCHEMBL30476694 0.78 EGFR (0.60) USP2CYP1A2CASP7CASP1MEN1
SCHEMBL30476695 0.77 EGFR (1.00) EGFRBTKITK
SCHEMBL29024854 0.77 EGFR (1.00) EGFRBTKITK
SCHEMBL7690766 0.76 CYP1A2 (0.73) USP2CYP1A2CASP7CASP1MEN1
SCHEMBL7694838 0.76 CYP1A2 (0.73) USP2CYP1A2CASP7CASP1MEN1
SCHEMBL27973564 0.75 JAK3 (0.65) USP2CYP1A2CASP7CASP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002076954-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES SMITHKLINE BEECHAM CORPORATION (US) 2002-10-03 WO disclosed